KLYG — Kelyniam Global Income Statement
0.000.00%
HealthcareSpeculativeMicro Cap
- $7.18m
- $7.47m
- $0.20m
Annual income statement for Kelyniam Global, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2006 December 31st | 2007 December 31st | 2008 December 31st | 2009 December 31st | 2010 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10KSB | 10KSB | ARS | ARS | ARS |
| Standards: | USG | USG | — | — | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.069 | 0.047 | 0.451 | 0.273 | 0.201 |
| Cost of Revenue | |||||
| Gross Profit | 0.069 | -0.053 | 0.302 | 0.17 | 0.084 |
| Selling / General / Administrative Expenses | |||||
| Total Operating Expenses | 0.079 | 0.22 | 0.658 | 0.47 | 0.441 |
| Operating Profit | -0.01 | -0.173 | -0.207 | -0.197 | -0.24 |
| Total Net Non Operating Interest Income / Expense | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -0.045 | -0.182 | -0.221 | -0.215 | -0.257 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -0.045 | -0.182 | -0.221 | -0.215 | -0.257 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -0.045 | -0.182 | -0.221 | -0.215 | -0.257 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | -0.045 | -0.182 | -0.221 | -0.215 | -0.257 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.003 | -0.011 | -0.011 | -0.017 | -0.02 |
| Dividends per Share |